申请人:Merck Patent Gesellschaft mit Beschrankter Haftu
公开号:US20130090385A1
公开(公告)日:2013-04-11
The invention relates to compounds of the general formula (I) wherein R1, R2, R3, R4, R5, R6, i and j have the meanings given in claim 1, and to the use thereof as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
该发明涉及一般式(I)的化合物,其中R1,R2,R3,R4,R5,R6,i和j具有权利要求1中给出的含义,并将其用作caspase-10抑制剂,特别用于治疗糖尿病视网膜病变。